Andrew Franklin
Director of Finance/CFO at ALLIANCE PHARMA PLC
Net worth: 96 747 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Butterfield | M | 49 |
Alliance Pharmaceuticals Ltd. (United Kingdom)
 Alliance Pharmaceuticals Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Alliance Pharma Plc, Alliance Pharmaceuticals Ltd. is a British UK-based company founded in 1996 by John Dawson. The private company is an international consumer healthcare business that offers trusted and proven brands to improve people's health and wellbeing. The company has a consistent track record of investing in both organic growth and acquisitions. The company works with a team of people, brands, and partners to achieve more for patients, healthcare providers, business partners, and investors. Peter Jonathan Butterfield has been the CEO of the company since 2010.
Maelor Laboratories Ltd.
 Maelor Laboratories Ltd. Medical DistributorsDistribution Services Founded in 1997, Maelor Laboratories Ltd. is a British pharmaceutical company that sells and markets pharmaceutical products and medical devices. Part of Alliance Pharma Plc, the private company is based in Chippenham, UK. | 14 years |
| John Dawson | M | - |
Alliance Pharmaceuticals Ltd. (United Kingdom)
Alliance Pharmaceuticals Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Alliance Pharma Plc, Alliance Pharmaceuticals Ltd. is a British UK-based company founded in 1996 by John Dawson. The private company is an international consumer healthcare business that offers trusted and proven brands to improve people's health and wellbeing. The company has a consistent track record of investing in both organic growth and acquisitions. The company works with a team of people, brands, and partners to achieve more for patients, healthcare providers, business partners, and investors. Peter Jonathan Butterfield has been the CEO of the company since 2010. | 28 years |
| Joanna Le Couilliard | F | 60 |
Alliance Pharmaceuticals Ltd. (United Kingdom)
Alliance Pharmaceuticals Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Alliance Pharma Plc, Alliance Pharmaceuticals Ltd. is a British UK-based company founded in 1996 by John Dawson. The private company is an international consumer healthcare business that offers trusted and proven brands to improve people's health and wellbeing. The company has a consistent track record of investing in both organic growth and acquisitions. The company works with a team of people, brands, and partners to achieve more for patients, healthcare providers, business partners, and investors. Peter Jonathan Butterfield has been the CEO of the company since 2010. | 5 years |
| David John Cook | M | 57 |
Alliance Pharmaceuticals Ltd. (United Kingdom)
Alliance Pharmaceuticals Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Alliance Pharma Plc, Alliance Pharmaceuticals Ltd. is a British UK-based company founded in 1996 by John Dawson. The private company is an international consumer healthcare business that offers trusted and proven brands to improve people's health and wellbeing. The company has a consistent track record of investing in both organic growth and acquisitions. The company works with a team of people, brands, and partners to achieve more for patients, healthcare providers, business partners, and investors. Peter Jonathan Butterfield has been the CEO of the company since 2010. | 10 years |
| Richard Jones | M | 58 |
Alliance Pharmaceuticals Ltd. (United Kingdom)
Alliance Pharmaceuticals Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Alliance Pharma Plc, Alliance Pharmaceuticals Ltd. is a British UK-based company founded in 1996 by John Dawson. The private company is an international consumer healthcare business that offers trusted and proven brands to improve people's health and wellbeing. The company has a consistent track record of investing in both organic growth and acquisitions. The company works with a team of people, brands, and partners to achieve more for patients, healthcare providers, business partners, and investors. Peter Jonathan Butterfield has been the CEO of the company since 2010. | 5 years |
| Nigel Clifford | M | 65 |
Alliance Pharmaceuticals Ltd. (United Kingdom)
Alliance Pharmaceuticals Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Alliance Pharma Plc, Alliance Pharmaceuticals Ltd. is a British UK-based company founded in 1996 by John Dawson. The private company is an international consumer healthcare business that offers trusted and proven brands to improve people's health and wellbeing. The company has a consistent track record of investing in both organic growth and acquisitions. The company works with a team of people, brands, and partners to achieve more for patients, healthcare providers, business partners, and investors. Peter Jonathan Butterfield has been the CEO of the company since 2010. | 9 years |
| Stephen Martin Kidner | M | 56 |
Maelor Laboratories Ltd.
Maelor Laboratories Ltd. Medical DistributorsDistribution Services Founded in 1997, Maelor Laboratories Ltd. is a British pharmaceutical company that sells and markets pharmaceutical products and medical devices. Part of Alliance Pharma Plc, the private company is based in Chippenham, UK. | 11 years |
| Eva-Lotta Sjöstedt | F | 57 | 1 years | |
| Jeyan Heper | M | - | 1 years | |
| Martin Sutherland | M | 55 | 1 years | |
| Chris Chrysanthouc | M | - | 7 years | |
| Kristof Leon Neirynck | M | 46 | 3 years | |
| Richard McKenzie | M | 52 | 1 years | |
| Janice Elizabeth Timberlake | F | - | 13 years | |
| Camillo Pane | M | 53 | - | |
| Alexander James Hanbury Duggan | M | 54 |
Maelor Laboratories Ltd.
Maelor Laboratories Ltd. Medical DistributorsDistribution Services Founded in 1997, Maelor Laboratories Ltd. is a British pharmaceutical company that sells and markets pharmaceutical products and medical devices. Part of Alliance Pharma Plc, the private company is based in Chippenham, UK. | - |
| Alex Duggan | M | - | 10 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anthony Richard Booley | M | - | 18 years | |
| Andrew Leonard Smith | M | - | 12 years | |
| Amir Rahim | M | - |
The University of Wales
| 7 years |
| Richard A. Moscicki | M | 72 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | 2 years |
| Richard Gboyega Asabia | M | 61 |
The University of Wales
| 2 years |
| Arild Bjørn Hansen | M | 55 |
The University of Wales
| 3 years |
| Ryan Lee | M | 55 |
The University of Wales
| 3 years |
| David C. Salcfas | M | - |
The University of Wales
| 4 years |
| Mohammad Zin bin Awang | M | 75 |
The University of Wales
| 1 years |
| Hari Sugiharto | M | 79 |
The University of Wales
| 1 years |
| Simon Thomas | M | 60 |
The University of Wales
| 4 years |
| Mark Everitt | M | - |
The University of Wales
| 3 years |
| Dan Thomas | M | - | 15 years | |
| Sze Yao Wang | M | 56 |
The University of Wales
| 4 years |
| Yau Chi Luk | M | 60 |
The University of Wales
| 4 years |
| Harold Gittlemon | M | - |
The University of Wales
| 4 years |
| Michael Francis | M | 58 |
The University of Wales
| 4 years |
| Susan Moran | M | 54 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | 4 years |
| Demetra Kalogerou | M | 55 |
The University of Wales
| 4 years |
| Mokgadi Khonziwe Nteta | F | 59 |
The University of Wales
| 4 years |
| Asmet bin Nasruddin | M | 57 |
The University of Wales
| 3 years |
| Kesavan Nair | M | 60 |
The University of Wales
| 3 years |
| Robin Bellhouse | M | 60 | 1 years | |
| Warren Pratt | M | 70 |
The University of Wales
| 3 years |
| Sandy Smith | M | 77 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | 15 years |
| Andrew J. Wilkinson | M | - |
The University of Wales
| 3 years |
| Simon Biancardi | M | - |
The University of Wales
| 3 years |
| Kam Yim Wong | M | 63 |
The University of Wales
| 1 years |
| Roderick Kirkham | M | 63 |
The University of Wales
| 3 years |
| Timothy J. Falla | M | 58 |
The University of Wales
| 4 years |
| Warren Harris | M | 61 |
The University of Wales
| 4 years |
| Zulkifli bin Mohamad Razali | M | 64 |
The University of Wales
| 1 years |
| Henrik Lawaetz | M | 69 |
The University of Wales
| 3 years |
| Shiu Chung Mak | M | 62 |
The University of Wales
| 2 years |
| Wing Ho Ha | M | 61 |
The University of Wales
| 3 years |
| Thomas Casdagli | M | 47 | 9 years | |
| Mike Fischer | M | 66 |
The University of Wales
| 3 years |
| Woon Jun Kong | M | 61 |
The University of Wales
| 4 years |
| Mohamed Ibrahim bin A. Wahid | M | 62 |
The University of Wales
| 3 years |
| Khoon Lim | M | 59 |
The University of Wales
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 57 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Andrew Franklin
- Personal Network
